Blanca Gonzalez, MD
Family Medicine · Hialeah, FLNPI 1598087280
Payments from drug & device makers
Across 114 payments — averaging $12,089 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astrazeneca UK Limited$776K
- Amgen$290K
- Hexal AG$189K
- Eli Lilly$112K
- Radius Health, Inc.$10K
- Medline Industries LP$160
- plus $259 from 6 others
Across 4 payments — averaging $1778.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$7K
What the payments were for
- Food & beverage$419100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astrazeneca UK Limited | 1 | $776,341 |
| Amgen | 3 | $290,364 |
| Hexal AG | 69 | $188,734 |
| Eli Lilly | 3 | $111,906 |
| Radius Health, Inc. | 12 | $10,407 |
| Medline Industries LP | 14 | $160 |
| Organogenesis Inc. | 3 | $80 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $65 |
| Inspire Medical Systems, Inc. | 1 | $45 |
| Genentech USA, Inc. | 2 | $29 |
| Sunovion Pharmaceuticals Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $20 |
How this compares
$1,378,172 in reported general payments places this provider in the 95th percentile of 7,282 family medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 27 | $25,810 |
| EliquisApixaban | 38 | $22,241 |
| FarxigaDapagliflozin Propanediol | 12 | $11,149 |
| EntrestoSacubitril/Valsartan | 15 | $9,994 |
| OzempicSemaglutide | 12 | $8,897 |
| MyrbetriqMirabegron | 12 | $7,733 |
| BrilintaTicagrelor | 12 | $5,199 |
| Memantine Hcl | 20 | $1,579 |
| Pantoprazole Sodium | 145 | $924 |
| Cephalexin | 28 | $547 |
| Atorvastatin Calcium | 98 | $479 |
| Nifedipine ErNifedipine | 19 | $457 |
| Metoprolol Succinate | 47 | $433 |
| Quetiapine Fumarate | 21 | $404 |
| Levothyroxine Sodium | 53 | $403 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Hialeah
- Dario AltamiranoHialeah$15.5M
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
- Christopher GallowayMelbourne$15.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.